home / stock / pacb / pacb news


PACB News and Press, Pacific Biosciences of California Inc. From 08/07/25

Stock Information

Company Name: Pacific Biosciences of California Inc.
Stock Symbol: PACB
Market: NASDAQ
Website: pacb.com

Menu

Get PACB Alerts

News, Short Squeeze, Breakout and More Instantly...

PACB - Pacific Biosciences of California Non-GAAP EPS of -$0.13 beats by $0.04, revenue of $39.8M beats by $3.33M

2025-08-07 16:09:24 ET More on Pacific Biosciences of California Pacific Biosciences: The Shift To Razor-Blade Economics Could Be A Game Changer Pacific Biosciences of California: Sell Before Potential Reverse Split Pacific Biosciences: A Mountain Of Red Flags ...

PACB - Expected US Company Earnings on Thursday, August 7th, 2025

Leatt Corp (LEAT) is expected to report for Q2 2025 MDU Resources Group Inc. (Holding Company) (MDU) is expected to report $0.13 for Q2 2025 Video Display Corp. (VIDE) is expected to report for quarter end 2025-05-31 Alarm.com Holdings Inc. (ALRM) is expected to report $0.38 for Q2 20...

PACB - Expected earnings - Pacific Biosciences of California Inc.

Pacific Biosciences of California Inc. (PACB) is expected to report $-0.18 for Q2 2025

PACB - Pacific Biosciences of California Q2 2025 Earnings Preview

2025-08-06 13:49:33 ET More on Pacific Biosciences of California Pacific Biosciences: The Shift To Razor-Blade Economics Could Be A Game Changer Pacific Biosciences of California: Sell Before Potential Reverse Split Pacific Biosciences: A Mountain Of ...

PACB - PacBio to Present at Upcoming Investor Conferences

MENLO PARK, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be participating in the following upcoming investor conferences: Canaccord Genuity 45th Annual Growth ...

PACB - Nature Methods Paper Leverages PacBio Sequencing Technology to Develop the Platinum Pedigree Benchmark, a New Standard for Accurate Characterization of Variation in the Human Genome that Improves Training for AI Models

MENLO PARK, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced the results of a study published in Nature Methods describing a new, comprehensive truth-set of genomic variation whic...

PACB - Earnings week ahead: AMD, PLTR, PFE, DIS, O, ET, SHOP, GILD, MCD, CAT, VTRS, BP, UBER, CGC, and more

2025-08-03 08:00:18 ET As Wall Street embarks on the first full week of August, the earnings wave continues with another stacked week of reports spanning tech, energy, healthcare, consumer, and industrial sectors offering a comprehensive read on corporate health, capital allocation, and dem...

PACB - Athena Diagnostics Improves Ataxia Movement Disorder Testing with Novel Long-Read Gene Sequencing

Athena Diagnostics Improves Ataxia Movement Disorder Testing with Novel Long-Read Gene Sequencing PR Newswire New test utilizes technology based on PacBio's PureTarget sequencing method to uncover genetic causes of disease BOSTON , July 29, 2025 /PRNewswi...

PACB - PacBio HiFi Sequencing Powers First Arab Human Pangenome, Published in Nature Communications

MENLO PARK, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced a significant advancement for global genomic equity. Researchers have published the first Arab human pangenome in Nature Co...

PACB - Pacific Biosciences: The Shift To Razor-Blade Economics Could Be A Game Changer

2025-07-23 11:05:00 ET I have written about Pacific Biosciences ("PacBio") ( PACB ) multiple times before. In my last analysis, I stated that the convertible debt the company issued would likely drag the stock. However, now that the company has broken through the $1 level th...

Previous 10 Next 10